269
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Safety, Tolerability, and Pharmacokinetics of Ibuprofenamine Hydrochloride Spray (NSAIDs), a New Drug for Rheumatoid Arthritis and Osteoarthritis, in Healthy Chinese Subjects

, , , , , & show all
Pages 629-638 | Published online: 16 Feb 2021

References

  • YeomansND, GrahamDY, HusniME, et al. Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial. Aliment Pharmacol Ther. 2018;47:1453–1463. doi:10.1111/apt.1461029667211
  • García-RayadoG, NavarroM, LanasA. NSAID induced gastrointestinal damage and designing GI-sparing NSAIDs. Expert Rev Clin Phar. 2018;11:1031–1043. doi:10.1080/17512433.2018.1516143
  • N’DaDD. Prodrug strategies for enhancing the percutaneous absorption of drugs. Molecules. 2014;19:20780–20807. doi:10.3390/molecules19122078025514222
  • MikulakSA, VangsnessCT, NimniME, et al. Transdermal delivery and accumulation of indomethacin in subcutaneous tissues in rats. J Pharm Pharmacol. 1998;50:153–158. doi:10.1111/j.2042-7158.1998.tb06170.x9530982
  • BjarnasonI, SancakO, CrossleyA, et al. Differing disintegration and dissolution rates, pharmacokinetic profiles and gastrointestinal tolerability of over the counter ibuprofen formulations. J Pharm Pharmacol. 2018;70:223–233. doi:10.1111/jphp.1282729238984
  • BjarnasonI, ScarpignatoC, TakeuchiK, et al. Determinants of the short-term gastric damage caused by NSAIDs in man. Aliment Pharm Ther. 2007;26:95–106. doi:10.1111/j.1365-2036.2007.03348.x
  • PrausnitzMR, LangerR. Transdermal drug delivery. Nat Biotechnol. 2008;26:1261–1268. doi:10.1038/nbt.150418997767
  • Al HanbaliA, KhanH, SarfrazM, et al. Transdermal patches: design and current approaches to painless drug delivery. Acta Pharm. 2019;69(2):197–215. doi:10.2478/acph-2019-001631259729
  • LewisF, ConnollyMP, BhattA, et al. A pharmacokinetic study of an ibuprofen topical patch in healthy male and female adult volunteers. Clin Pharm Drug Dev. 2018;7:684–691. doi:10.1002/cpdd.423
  • UnderwoodM, AshbyD, CrossP, et al. Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study. BMJ. 2008;336:138–142. doi:10.1136/bmj.39399.656331.2518056743
  • CampbellJ, DunnT. Evaluation of topical ibuprofen cream in the treatment of acute ankle sprains. Emerg Med J. 1994;11(3):178–182. doi:10.1136/emj.11.3.178
  • TisoRL, Tong-NgorkS, FredlundKL. Oral versus topical ibuprofen for chronic knee pain: a prospective randomized pilot study. Pain Physician. 2010;13:457–467.20859315
  • DerryS, ConaghanP, Da SilvaJA, et al. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2008;4:CD007400.
  • IrvineJ, AfroseA, IslamN. Formulation and delivery strategies of ibuprofen: challenges and opportunities. Drug Dev Ind Pharm. 2018;44:173–183. doi:10.1080/03639045.2017.139183829022772
  • GuR, HeY, HanS, et al. Pharmacokinetics and bioavailability of tuftsin-derived T peptide, a promising antitumor agent, in beagles. Drug Metab Pharmacok. 2016;31:51–56. doi:10.1016/j.dmpk.2015.08.005
  • KivistoKT, KallioA, NeuvonenPJ. Pharmacokinetics and pharmacodynamics of transdermal dexmedetomidine. Eur J Clin Pharmacol. 1994;46:345–349. doi:10.1007/BF001944037957520
  • LiuW, TengL, YuK, et al. Design of hydrogels of 5-hydroxymethyl tolterodine and their studies on pharmacokinetics, pharmacodynamics and transdermal mechanism. Eur J Pharm Sci. 2017;96:530–541. doi:10.1016/j.ejps.2016.10.02427789373
  • ParkI, KimD, SongJ, et al. BupredermTM, a new transdermal delivery system of buprenorphine: pharmacokinetic, efficacy and skin irritancy studies. Pharm Res. 2008;25:1052–1062. doi:10.1007/s11095-007-9470-618236140